The Food and Drug Administration (FDA) has now approved several GLP-1 medications for chronic weight management in adults with obesity
Interaction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells
Aggregation This describes the clustering of multiple peptide molecules into larger complexes
The tesamorelin + ipamorelin blend half life we've discussed throughout this piece applies exclusively to subcutaneous or intravenous administration of intact, lyophilised, reconstituted peptides synthesized under GMP conditions with verified amino acid sequencing
So this is a growing threat that I think needs to be monitored closely. If GLP-1s do become prohibited, athletes could theoretically apply for a therapeutic use exemption (TUE), which allows them to take a drug if it is treating a legitimate medical condition, and does not meaningfully enhance their performance
Where required, we facilitate COA availability and support SDS/MSDS requests